Kistler-Tiffany Companies’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $264K | Buy |
2,076
+5
| +0.2% | +$650 | 0.04% | 293 |
|
|
2023
Q1 | $268K | Hold |
2,071
| – | – | 0.05% | 255 |
|
|
2022
Q4 | $272K | Hold |
2,071
| – | – | 0.06% | 208 |
|
|
2022
Q3 | $242K | Hold |
2,071
| – | – | 0.06% | 184 |
|
|
2022
Q2 | $244K | Hold |
2,071
| – | – | 0.05% | 186 |
|
|
2022
Q1 | $270K | Buy |
2,071
+1
| +0% | +$130 | 0.05% | 188 |
|
|
2021
Q4 | $316K | Hold |
2,070
| – | – | 0.06% | 158 |
|
|
2021
Q3 | $335K | Sell |
2,070
-891
| -30% | -$150K | 0.08% | 141 |
|
|
2021
Q2 | $485K | Sell |
2,961
-697
| -19% | -$107K | 0.11% | 116 |
|
|
2021
Q1 | $551K | Buy |
3,658
+491
| +16% | +$78K | 0.14% | 99 |
|
|
2020
Q4 | $480K | Buy |
3,167
+210
| +7% | +$30K | 0.14% | 95 |
|
|
2020
Q3 | $400K | Hold |
2,957
| – | – | 0.13% | 105 |
|
|
2020
Q2 | $404K | Sell |
2,957
-640
| -18% | -$81.6K | 0.14% | 94 |
|
|
2020
Q1 | $434K | Hold |
3,597
| – | – | 0.15% | 87 |
|
|
2019
Q4 | $434K | Sell |
3,597
-2,337
| -39% | -$261K | 0.15% | 89 |
|
|
2019
Q3 | $590K | Hold |
5,934
| – | – | 0.22% | 65 |
|
|
2019
Q2 | $647K | Buy |
5,934
+10
| +0.2% | +$1.06K | 0.25% | 62 |
|
|
2019
Q1 | $662K | Buy |
5,924
+676
| +13% | +$74.1K | 0.27% | 61 |
|
|
2018
Q4 | $506K | Sell |
5,248
-216
| -4% | -$22.9K | 0.24% | 69 |
|
|
2018
Q3 | $666K | Buy |
5,464
+2
| +0% | +$236 | 0.28% | 62 |
|
|
2018
Q2 | $600K | Sell |
5,462
-1,175
| -18% | -$126K | 0.27% | 69 |
|
|
2018
Q1 | $708K | Buy |
6,637
+179
| +3% | +$19.8K | 0.29% | 62 |
|
|
2017
Q4 | $690K | Buy |
6,458
+287
| +5% | +$30.7K | 0.27% | 64 |
|
|
2017
Q3 | $686K | Buy |
6,171
+192
| +3% | +$20.5K | 0.29% | 61 |
|
|
2017
Q2 | $618K | Buy |
5,979
+294
| +5% | +$29K | 0.28% | 60 |
|
|
2017
Q1 | $556K | Buy |
5,685
+1,587
| +39% | +$152K | 0.26% | 61 |
|
|
2016
Q4 | $363K | Buy |
4,098
+1,272
| +45% | +$116K | 0.18% | 83 |
|
|
2016
Q3 | $273K | Buy |
2,826
+207
| +8% | +$19.7K | 0.13% | 99 |
|
|
2016
Q2 | $225K | Buy |
2,619
+2,442
| +1,380% | +$219K | 0.12% | 109 |
|
|
2016
Q1 | $15K | Buy |
177
+69
| +64% | +$6.17K | 0.01% | 385 |
|
|
2015
Q4 | $12K | Hold |
108
| – | – | 0.01% | 424 |
|
|
2015
Q3 | $11K | Hold |
108
| – | – | 0.01% | 432 |
|
|
2015
Q2 | $13K | Sell |
108
-93
| -46% | -$11.1K | 0.01% | 433 |
|
|
2015
Q1 | $23K | Buy |
201
+93
| +86% | +$10.3K | 0.01% | 343 |
|
|
2014
Q4 | $11K | Hold |
108
| – | – | 0.01% | 428 |
|
|
2014
Q3 | $10K | Buy |
+108
| New | +$9.48K | 0.01% | 447 |
|
Other funds holding IBB
CB
Kistler-Tiffany Companies's IBB Position: Q2 2023 in Review
Kistler-Tiffany Companies increased its iShares Biotechnology ETF (IBB) stake by 0.24% in Q2 2023, buying an estimated $650 and bringing the position to 2,076 shares worth $264K. The position accounts for 0.04% of the portfolio, ranked #293.
Kistler-Tiffany Companies first reported a position in IBB in Q3 2014 and has held it in 36 quarters since. The position peaked at $708K in Q1 2018. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.
- Kistler-Tiffany Companies held 2,076 shares of iShares Biotechnology ETF worth $264K as of Q2 2023.
- Kistler-Tiffany Companies bought 5 iShares Biotechnology ETF shares in Q2 2023, an estimated $650.
- iShares Biotechnology ETF made up 0.04% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #293 holding.
- Kistler-Tiffany Companies first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 36 quarters since.
- Kistler-Tiffany Companies's iShares Biotechnology ETF position peaked at $708K in Q1 2018.
- 843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.